Abstract
Glycyl-glutamine (Gly-Gln) is an endogenous dipeptide that is synthesized from β-endorphin post-translationally. Previously, we showed that Gly-Gln prevents acquisition of morphine-conditioned place preference, a behavioral test of morphine reward, but does not interfere with morphine analgesia. In this study, we tested the hypothesis that Gly-Gln inhibits morphine reward by blocking morphine-induced dopamine efflux in the nucleus accumbens (NAc). Extracellular dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) were sampled by microdialysis and analyzed by high-performance liquid chromatography with electrochemical detection. Guide cannulas were implanted in the right NAc and left lateral ventricle of male Sprague–Dawley rats stereotaxically. Approximately 24 h later, a microdialysis probe was inserted into the NAc and perfused at 1 µl/min. Gly-Gln (1, 3, 30, or 100 nmol/5 µl) or saline was administered intracerebroventricularly, morphine (2.5 mg/kg) was injected intraperitoneally (i.p.) 2 min later, and extracellular dopamine and DOPAC were sampled at 20-min intervals. Morphine administration increased extracellular dopamine concentrations by approximately 600% within 40 min. Gly-Gln pretreatment inhibited the rise in extracellular dopamine in a dose-related manner; the lowest significantly inhibitory dose was 1 nmol. Gly-Gln also inhibited the morphine-induced rise in extracellular DOPAC concentrations but did not affect extracellular dopamine or DOPAC in control animals. Gly-Gln (100 nmol/5 µl) prevented morphine-induced dopamine efflux in rats treated with morphine chronically (10 mg/kg, i.p. twice daily for 6 days), although it did not affect DOPAC concentrations significantly. These data support the hypothesis that Gly-Gln abolishes the rewarding effect of morphine by inhibiting the ability of morphine to stimulate dopamine release in the NAc.
Similar content being viewed by others
References
Akil H, Young E, Watson SJ, Coy DH (1981) Opiate binding properties of naturally occurring N- and C-terminus modified beta-endorphins. Peptides 2:289–292. doi:10.1016/S0196-9781(81)80121-0
Bals-Kubik R, Herz A, Shippenberg TS (1988) β-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. N-S Arch Pharmacol 338:392–396. doi:10.1007/BF00172115
Bechara A, Nader K, van der Kooy D (1998) A two-separate-motivational-systems hypothesis of opioid addiction. Pharmacol Biochem Behav 59:1–17. doi:10.1016/S0091-3057(97)00047-6
Bicknell AB (2008) The tissue specific processing of pro-opiomelanocortin. J Neuroendocrinology 20:692–699. doi:10.1111/j.1365-2826.2008.01709.x
Bronstein DM, Przewlocki R, Akil H (1990) Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res 519(1–2):102–111. doi:10.1016/0006-8993(90)90066-K
Cavun S, Göktalay G, Millington WR (2005) Glycyl-glutamine, an endogenous β-endorphin derived peptide, inhibits morphine conditioned place perefrence, tolerance, dependence and withdrawal. J Pharmacol Exp Ther 315:949–958. doi:10.1124/jpet.105.091553
Deakin JF, Doströvsky JO, Smyth DG (1980) Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of β-endorphin. Biochem J 189:501–506. doi:0306-3275/80/090501-06$01.50/1
DeBoer AG, Sutanto W (1997) Drug transport across the blood brain barrier in vitro and in vivo techniques. Harwood Academic Publishers, Amsterdam, p 168
Göktalay G, Cavun S, Levendusky MC, Hamilton JR, Millington WR (2006) Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal. Eur J Pharmacol 530:95–102. doi:10.1016/j.ejphar.2005.11.034
Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, Ashby CR (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49:77–105. doi:10.1016/j.brainresrev.2004.12.033
Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403–1413
Ma YY, Meng L, Guo CY, Han JS, Lee DY, Cui CL (2009) Dose-and time-dependent, context-induced elevation of dopamine and its metabolites in the nucleus accumbens of morphine-induced CPP rats. Behav Brain Res 204(1):192–199. doi:10.1016/j.bbr.2009.06.017
Manzanedo C, Aguilar MA, Rodríguez-Arias M, Miñarro J (2001) Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res 121(1–2):189–197. doi:10.1016/S0166-4328(01)00164-4
Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445–1449. doi:10.1038/nn1578
Nicolas P, Li CH (1985) β-Endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia. Proc Natl Acad Sci USA 82(10):3178–3181
Owen MD, Unal CB, Callahan MF, Triveda K, York C, Millington WR (2000) Glycyl- glutamine inhibits the respiratory depression, but not the antinociception, produced by morphine. Am J Physiol Regul Integr Comp Physiol 279:1944–1948. doi:0363-6119/00$5.00
Parish DC, Smyth DG, Normanton JR, Wolstencroft JH (1983) Glycyl-glutamine, an inhibitory neuropeptide derived from beta-endorphin. Nature 306:267–270. doi:10.1038/306267a0
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New York
Raffin-Sanson ML, de Keyzer Y, Bertagna X (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149:79–90. doi:10.1530/eje.0.1490079
Resch GE, Simpson CW (2008) Glycyl-glutamine reduces ethanol intake at three reward sites in P rats. Alcohol 42(2):99–106. doi:10.1016/j.alcohol.2007.11.002
Resch GE, Shridharani S, Millington WR, Garris DR, Simpson CW (2005) Glycyl-L-glutamine in nucleus accumbens reduces ethanol intake in alcohol preferring (P) rats. Brain Res 1058:73–81. doi:10.1016/j.brainres.2005.07.066
Shippenberg TS, Elmer GI (1998) The neurobiology of opiate reinforcement. Crit Rev Neurobiol 12(4):267–303
Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265(1):53–59
Simpson CW, Resch GE, Millington WR, Myers RD (1998) Glycyl-L-glutamine injected centrally suppresses alcohol drinking in P rats. Alcohol 16(2):101–107. doi:10.1016/S0741-8329(97)00167-5
Smith DJ, Robertson B, Monroe PJ, Taylor DA, Leedham JA, Cabral JD (1992) Opioid receptors mediating antinociception from β-endorphin and morphine in the periaqueductal gray. Neuropharmacology 31(11):1137–1150. doi:10.1016/0028-3908(92)90010-M
Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22(11):521–527. doi:10.1016/S0166-2236(99)01447-2
Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS (1991) β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology 104:51–56. doi:10.1007/BF02244553
Tseng LF (2001) Evidence for epsilon-opioid receptor-mediated β-endorphin-induced analgesia. Trends Pharmacol Sci 22(12):623–630. doi:10.1016/S0165-6147(00)01843-5
Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613–672. doi:10.1016/S0301-0082(98)00060-4
Unal CB, Owen MD, Millington WR (1994) Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing. J Pharmacol Exp Ther 271:952–958. doi:0022-3565/94/2712-0952$03.00/0
Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225. doi:10.1146/annurev.ps.40.020189.001203
Zakarian S, Smyth DG (1982) Distribution of β-endorphin-related peptides in rat pituitary and brain. Biochem J 202(3):561–571. doi:0306-3283/82/030561-13$01.50/1
Acknowledgements
This research was supported by grants from TÜBİTAK and Uludag University BAP. We are grateful to Dr. Ozhan Eyigor (Uludag University Faculty of Medicine Department of Histology and Embryology).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basaran, N.F., Buyukuysal, R.L., Millington, W.R. et al. Glycyl-glutamine (β-endorphin30-31) inhibits morphine-induced dopamine efflux in the nucleus accumbens. Naunyn-Schmied Arch Pharmacol 381, 467–475 (2010). https://doi.org/10.1007/s00210-010-0507-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-010-0507-8